CIK 0000885590 · Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- Phone
- 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $258,894
- in 1 filing, $259K under 10b5-1 plans
Net −$258,894. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-17 | Miller Steven D Director | Grant or award | +35,360 | 174,877 | ||
| 2024-05-17 | KAVANAGH SARAH B Director | Grant or award | +35,360 | 182,012 | ||
| 2024-05-17 | ICAHN BRETT Director | Grant or award | +35,360 | 143,860 | ||
| 2024-03-29 | Paulson John Director | Grant or award | +5,890 | $10.61 | $62K | 208,309 |
| 2024-03-29 | ICAHN BRETT Director | Grant or award | +3,122 | $10.61 | $33K | 108,500 |
| 2024-03-29 | ROBERTSON RUSSEL C Director | Grant or award | +2,945 | $10.61 | $31K | 225,279 |
| 2024-03-29 | WECHSLER AMY B Director | Grant or award | +647 | $10.61 | $7K | 169,906 |
| 2024-03-04 | Carson Seana EVP, General Counsel | Sale 10b5-1 | −4,420 | $9.80 | $43K | 501,798 |
| 2024-03-04 | Carson Seana EVP, General Counsel | Sale 10b5-1 | −199 | $9.80 | $2K | 501,599 |
| 2024-03-04 | Carson Seana EVP, General Counsel | Sale 10b5-1 | −1,561 | $9.80 | $15K | 500,038 |
| 2024-03-04 | Carson Seana EVP, General Counsel | Sale 10b5-1 | −133 | $9.80 | $1K | 499,905 |
| 2024-03-01 | Barresi John S SVP, Controller & CAO | Shares withheld for taxes | −3,188 | $9.89 | $32K | 107,064 |
| 2024-03-01 | APPIO THOMAS Chief Executive Officer | Shares withheld for taxes | −2,895 | $9.89 | $29K | 1,483,443 |
| 2024-03-01 | APPIO THOMAS Chief Executive Officer | Shares withheld for taxes | −2,413 | $9.89 | $24K | 1,481,030 |
| 2024-03-01 | APPIO THOMAS Chief Executive Officer | Shares withheld for taxes | −23,871 | $9.89 | $236K | 1,457,159 |
| 2024-03-01 | APPIO THOMAS Chief Executive Officer | Shares withheld for taxes | −87,803 | $9.89 | $868K | 1,369,356 |
| 2024-03-01 | Carson Seana EVP, General Counsel | Shares withheld for taxes 10b5-1 | −765 | $9.89 | $8K | 529,696 |
| 2024-03-01 | Carson Seana EVP, General Counsel | Shares withheld for taxes 10b5-1 | −5,994 | $9.89 | $59K | 523,702 |
| 2024-03-01 | Carson Seana EVP, General Counsel | Shares withheld for taxes 10b5-1 | −16,973 | $9.89 | $168K | 506,729 |
| 2024-03-01 | Carson Seana EVP, General Counsel | Shares withheld for taxes 10b5-1 | −511 | $9.89 | $5K | 506,218 |
Page 7 of 23 · 453 trades